Yoshihide Hirohata

Statistics

Publications

Citations

758

H-Index

Active since

1992

Affiliations

University of Occupational and Environmental Health Japan(Current)

Richard L. Roudebush VA Medical Center

Bayer (Germany)

Steno Diabetes Centers

University of Copenhagen

Yoshihide Hirohata is an author at University of Occupational and Environmental Health Japan specializing in medicine, pharmacology, and pharmacotherapy.

Publications per year

1992–2025

Publications

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

Paresh Dandona, Pieter Gillard, Peter Senior et al. · Diabetes Care · 2018 · 252 citations

Medicine, Pharmacology, Pharmacotherapy +15

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +17

Pancreatic cancer complicated by disseminated intravascular coagulation associated with production of tissue factor

Chisato Ueda, Yoshihide Hirohata, Yasuyuki Kihara et al. · Journal of Gastroenterology · 2001 · 50 citations

Medicine, Oncology, Pathology +16

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

Ellen Burgess, Rajiv Agarwal, Stefan D. Anker et al. · Diabetes Care · 2022 · 35 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

1–5 of 11